Search

everythinglearnresearchcommunity

for

Search:↓

Rubbing vitamin D3 on skin can help prevent hair loss from chemotherapy and slow breast tumor growth in mice.

Glucocorticoid corticosteroids improve muscle strength in Duchenne muscular dystrophy but can cause side effects.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Dupilumab effectively treated severe alopecia areata in a child.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Elental is a good long-term treatment for Crohn's disease, similar to 6-mercaptopurine but with fewer side effects.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Rituximab improved her dermatomyositis better than usual treatments.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Tofacitinib taken by mouth helps treat hair loss in children.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Tofacitinib may help regrow hair in alopecia areata patients.

A vitamin D receptor mutation causes rickets and affects immune responses.

Apremilast shows promise for several skin conditions but needs more research.